Advent Pharma Ltd. (DSE:ADVENT)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
13.60
-0.20 (-1.45%)
At close: Dec 4, 2025
-23.60%
Market Cap 1.27B
Revenue (ttm) 500.49M
Net Income (ttm) 66.87M
Shares Out 93.13M
EPS (ttm) 0.72
PE Ratio 18.94
Forward PE n/a
Dividend 0.05 (0.37%)
Ex-Dividend Date Nov 23, 2025
Volume 43,976
Average Volume 161,312
Open 13.50
Previous Close 13.80
Day's Range 13.50 - 13.80
52-Week Range 11.50 - 18.30
Beta 0.36
RSI 47.55
Earnings Date Oct 26, 2025

About Advent Pharma

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides its products in powder, bolus, and liquid dosage forms. It offers Yea-Sacc Bolus, Bioplex Dairy Max Bolus, SUPERIOR SYN BIOTECH, Oxi-D Bolus, and TOXOSORB. Advent Pharma Ltd. was incorporated in 2007 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 317
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ADVENT
Full Company Profile

Financial Performance

In 2025, Advent Pharma's revenue was 500.49 million, a decrease of -12.45% compared to the previous year's 571.67 million. Earnings were 66.87 million, a decrease of -20.38%.

Financial Statements

News

There is no news available yet.